knowledge -WSS

knowledge

author：hotspot 2025-08-24 10:14:46 - browse：389

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： FDA panel signals lack of confidence in Amgen cancer drug data

WSS

Medical devices makers are asking for forgiveness, not permission

U.K. officials, researchers try to ease path for bespoke genetic treatments

Why age limits for politicians are a terrible idea

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Why Charlie Gard's case is so disturbing to Americans

Sana to lay off nearly a third of staff, de

explore

knowledge

hotspot

Virginia high school admissions case could be legal follow

Was Amgen transparent enough on FDA's concern on cancer drug?

Virginia high school admissions case could be legal follow

Senate panel eyes new effort on drug shortages

Malaria cases in Florida and Texas: Here’s what you need to know

VC firm General Catalyst wants to buy a health system

Continuity nursing helped my family in our darkest PICU moments

Bristol 'take

In Memoriam: Notable people who died in 2023

Analysis of telehealth claims data suggest service duplication

focus

FDA authorizes Novavax’s updated Covid

Readout LOUD podcast, live from the STAT Breakthrough Summit East

A virus, fished out of a lake, may have saved a man’s life

Pregnancy ages women, but effects reverse after delivery

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Bring on the sabbaticals for nurses

focus

hotspot

knowledge

Wikipedia